Bart Teeuw Email & Phone Number

Amsterdam, Nh, Nl

Brussels, Be

Brussels, Be

Brussels, Be

Site Head PV The Netherlands and Chairman Netherlands Coordination Team (NLCT).Member PV senior leadership team, participates in creation and execution of PV mission, objectives and 3-5 year strategic plan and ensures effective translation and execution into annual functional operating plans such that Astellas' and PV strategic goals are achieved. Accountable for optimal development, allocation and management globally of global PV Process and PV Information Management staff, processes, systems and resources.Accountable for leading, executing and overseeing worldwide ICSR activities and submissions to ensure regulatory compliance of all in-house and outsourced case processing, as well as for global PV technology roadmap and strategies and management and operations of PV technological systems and applications and system data analysis/reporting.Develops and sustains high quality processes that allow for high medical quality and strict regulatory compliance with expedite reporting; including the collection, assessment, coding and reporting of safety information as required and the medical review of patients medical and technical complaints.Accountable for providing strategic process leadership and support to the global PV management team and PV Process and PV Information Management leads on matters relating to Pharmacovigilance.Drives and leads the strategic direction for PV systems/technologies/applications, case processing, literature and vendor management.Accountable for designing and establishing the best practices for case processing in line with the highest standards of PV in terms of timelines and high quality.

Member GPV senior leadership team, participates in creation and execution of GPV mission, objectives and 3-5 year strategic plan and ensures effective translation and execution into annual functional operating plans such that GPV strategic goals are achieved. Responsible for optimal development, allocation and management globally of Global PV Process staff, processes, systems and resources.Responsible for leading, executing and overseeing worldwide ICSR activities and submissions to ensure regulatory compliance of all in-house and outsourced case processing. Develops and sustains high quality processes that allow for high medical quality and strict regulatory compliance with expedite reporting; including the collection, assessment, coding and reporting of safety information as required and the medical review of patients medical and technical complaints.Responsible for providing strategic process leadership and support to the global PV management team and PV Process leads on matters relating to Pharmacovigilance.Drives and leads the strategic direction for case processing and vendor management.Accountable for designing and establishing the best practices for case processing in line with the highest standards of PV in terms of timelines and high quality.

Leading Drug Safety & Pharmacovigilance department and functionally Drug Safety Officers (DSOs) in APEL Local Country Affiliates/Astellas InternationalMember Global Pharmacovigilance Committee (GPC) Determine Astellas Europe, Middle East & Africa policy and strategy with respect to Pharmacovigilance and Pharmacoepidemiology Representing Astellas Pharmacovigilance for Europe, Middle East & AfricaEnsure PV inspection readiness in region in close collaboration with Astellas EU QPPV and other regionsLead reorganisation and restructuring of DSP organisation in the Netherlands including finalization of Works Council advice

Rahway, New Jersey, Us

Lead for Schering-Plough to succesful integration plan for QPPV Office organisation into Merck Compliance (until September 2011)Lead to perform major reengineering of global Schering-Plough/Intervet Animal Health PV system and organisation in anticipation of merger with Sanofi-Aventis Animal Health (Merial) and – upon cancellation of merger – within independent Merck Animal Health Business Unit

Kenilworth, New Jersey, Us

Chair of Justification Body of SPPF Pension FundRepresent employer (Schering-Plough / NV Organon) in SPPF

Kenilworth, New Jersey, Us

Business integration lead for Organon for integration and restructuring of Global Drug Safety organisation into Schering-Plough Global Pharmacovigilance

Jersey City, Nj, Us

Leading Global Drug Safety Organisation and QPPV for NV Organon product portfolioDetermine Organon policy and strategy with respect to Drug Safety and EpidemiologyLeading the Global Drug Safety (Surveillance) teams (N=300) in the NL HQ (Oss), US (Roseland, NJ), Japan (Osaka) and functionally Local Operating Countries (Drug Safey Officers)Member of Management Team Organon International, reporting to CMO Succesful reorganisation and restructuring of global PV organisation in the Netherlands over 2006 - early 2007Identification and implementation of new global safety IT system (ARISg) for Organon Global Drug Safety

Naarden, None, Nl

Reorganisation and reengineering of EU PV organisation in the Netherlands (2001/2002)Succesful integration of Sangstat PV organisation (Lyon, France) into European PV team (Naarden, NL)EU Lead for identification and implementation of new global safety IT system (Argus) for Genzyme Global Pharmacovigilance (2004/2005)Co-Lead Genzyme CQUIP (Continuous Quality Improvement Project in PV)

Management of (Pharmaco)vigilance, quality and epidemiology projects for global, European and national biopharmaceutical & medical device industry Lead ISO 9001 certification (2000/2001)Leading PV & QA consultant & operational team (Rotterdam, NL)

Utrecht, Utrecht, Nl

Dept Pharmacoepidemiology & PharmacotherapyQuality of Life research

Utrecht, Utrecht, Nl

Eijkman - Winkler Laboratory , Dept. of Medical Microbiology

Phd, Medicine

Msc, Biomedical Sciences